bacillus coagulans
Cell therapyexperimental
Heyndrickxia coagulans is a lactic acid–forming bacterial species. This species was transferred to Weizmannia in 2020, then to Heyndrickxia in 2023. — Wikipedia
Clinical trial activity
18 trials · 24 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
2
Earliest trial started Jun 1, 2008 (NCT00881322)
Timeline
Indications
Approved for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHeyndrickxia coagulans ↗
- WikipediaBacillus coagulans ↗
Also known as
- bacillus coagulans
- bacillus coagulans mtcc 5856
- b. coagulans
- coagulans gbi-30, 6086
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07187492 | Phase 4 | Sep 20, 2025 | People's Liberation Army of China |
| NCT06593834 | N/A | Sep 27, 2024 | Huazhong University of Science and Technology |
| NCT05635474 | N/A | Sep 25, 2022 | Taipei Medical University, TCI Co., Ltd. |
| NCT05483660 | Phase 2 | Aug 1, 2022 | Southern Medical University |
| NCT05064930 | N/A | Sep 1, 2021 | Medical University of Lublin, Nordic Bioscience |
| NCT04997187 | N/A | Jul 20, 2021 | Pusan National University |
| NCT06644001 | N/A | Jul 1, 2021 | Kerry, Peking University |
| NCT05367453 | N/A | Feb 22, 2021 | Go Fruselva, S.L., Universidad Autonoma de Madrid |
| NCT04758845 | N/A | Feb 11, 2021 | Deerland Enzymes, Health Center Nova Gorica |
| NCT05313178 | N/A | Nov 20, 2020 | Increnovo, LLC, Lindenwood University |
| NCT04457661 | N/A | Jul 13, 2020 | TCI Co., Ltd. |
| NCT04427020 | N/A | Aug 8, 2019 | Lindenwood University |
| NCT03857425 | Phase 4 | Mar 1, 2019 | People's Liberation Army of China |
| NCT03220802 | N/A | Sep 22, 2017 | Medical University of Graz |
| NCT02868489 | N/A | Dec 1, 2016 | Loma Linda University |
| NCT02762968 | N/A | Apr 1, 2016 | Metabolic Technologies, University of Central Florida |
| NCT02176889 | Phase 1 | Jun 1, 2014 | KGK Science Inc., Sabinsa Corporation |
| NCT00881322 | N/A | Jun 1, 2008 | Ganeden Biotech, Inc., MRA Clinical Research |
Showing 18 of 18 trials
Page 1 / 1
Organizations
Research & Development (24)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lindenwood University | Academic/Hospital | 2 | 2 | 1 | 2019 |
| People's Liberation Army of China | Government | 2 | 2 | 1 | 2019 |
| TCI Co., Ltd. | For profit | 2 | 1 | 1 | 2020 |
| Deerland Enzymes | For profit | 1 | 1 | 1 | 2021 |
| Ganeden Biotech, Inc. | For profit | 1 | 0 | 1 | 2008 |
| Go Fruselva, S.L. | For profit | 1 | 0 | 1 | 2021 |
| Health Center Nova Gorica | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Increnovo, LLC | For profit | 1 | 0 | 1 | 2020 |
| Kerry | For profit | 1 | 1 | 1 | 2021 |
| KGK Science Inc. | For profit | 1 | 1 | 1 | 2014 |
| Loma Linda University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Medical University of Graz | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Medical University of Lublin | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Metabolic Technologies | For profit | 1 | 1 | 1 | 2016 |
| MRA Clinical Research | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Nordic Bioscience | For profit | 1 | 1 | 1 | 2021 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Pusan National University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Sabinsa Corporation | For profit | 1 | 0 | 1 | 2014 |
24 organizations
Page 1 / 2